Alchemical free energy methods for drug discovery: progress and challenges

被引:437
作者
Chodera, John D. [2 ]
Mobley, David L. [3 ]
Shirts, Michael R. [4 ]
Dixon, Richard W. [5 ]
Branson, Kim [5 ]
Pande, Vijay S. [1 ]
机构
[1] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[2] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA
[3] Univ New Orleans, New Orleans, LA 70148 USA
[4] Univ Virginia, Charlottesville, VA 22904 USA
[5] Vertex Pharmaceut, Cambridge, MA 02139 USA
基金
美国国家科学基金会;
关键词
BINDING FREE-ENERGY; SOLVATION FREE-ENERGIES; MOLECULAR-DYNAMICS SIMULATIONS; IMPLICIT SOLVENT SIMULATIONS; HYDRATION FREE-ENERGIES; HELIX-COIL TRANSITION; SIDE-CHAIN ANALOGS; LIGAND-BINDING; FORCE-FIELDS; EFFICIENT;
D O I
10.1016/j.sbi.2011.01.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Improved rational drug design methods are needed to lower the cost and increase the success rate of drug discovery and development. Alchemical binding free energy calculations, one potential tool for rational design, have progressed rapidly over the past decade, but still fall short of providing robust tools for pharmaceutical engineering. Recent studies, especially on model receptor systems, have clarified many of the challenges that must be overcome for robust predictions of binding affinity to be useful in rational design. In this review, inspired by a recent joint academic/industry meeting organized by the authors, we discuss these challenges and suggest a number of promising approaches for overcoming them.
引用
收藏
页码:150 / 160
页数:11
相关论文
共 115 条
[91]   Error analysis and efficient sampling in Markovian state models for molecular dynamics [J].
Singhal, N ;
Pande, VS .
JOURNAL OF CHEMICAL PHYSICS, 2005, 123 (20)
[92]   SAMPL2 challenge: prediction of solvation energies and tautomer ratios [J].
Skillman, A. Geoffrey ;
Geballe, Matthew T. ;
Nicholls, Anthony .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (04) :257-258
[93]   Exploring the helix-coil transition via all-atom equilibrium ensemble simulations [J].
Sorin, EJ ;
Pande, VS .
BIOPHYSICAL JOURNAL, 2005, 88 (04) :2472-2493
[94]   A multistep approach to structure-based drug design: Studying ligand binding at the human neutrophil elastase [J].
Steinbrecher, T ;
Case, DA ;
Labahn, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) :1837-1844
[95]   Nonlinear scaling schemes for Lennard-Jones interactions in free energy calculations [J].
Steinbrecher, Thomas ;
Mobley, David L. ;
Case, David A. .
JOURNAL OF CHEMICAL PHYSICS, 2007, 127 (21)
[96]   Bornyl (3,4,5-trihydroxy)-cinnamate - An optimized human neutrophil elastase inhibitor designed by free energy calculations [J].
Stembrecher, Thomas ;
Hrenn, Andrea ;
Dormann, Korinna L. ;
Merfort, Irmgard ;
Labahn, Andreas .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) :2385-2390
[97]   Molecular simulation with variable protonation states at constant pH [J].
Stern, Harry A. .
JOURNAL OF CHEMICAL PHYSICS, 2007, 126 (16)
[98]   SEMIANALYTICAL TREATMENT OF SOLVATION FOR MOLECULAR MECHANICS AND DYNAMICS [J].
STILL, WC ;
TEMPCZYK, A ;
HAWLEY, RC ;
HENDRICKSON, T .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (16) :6127-6129
[99]   Influenza neuraminidase inhibitors: Structure-based design of a novel inhibitor series [J].
Stoll, V ;
Stewart, KD ;
Maring, CJ ;
Muchmore, S ;
Giranda, V ;
Gu, YGY ;
Wang, G ;
Chen, YW ;
Sun, MH ;
Zhao, C ;
Kennedy, AL ;
Madigan, DL ;
Xu, YB ;
Saldivar, A ;
Kati, W ;
Laver, G ;
Sowin, T ;
Sham, HL ;
Greer, J ;
Kempf, D .
BIOCHEMISTRY, 2003, 42 (03) :718-727
[100]   GPU-accelerated molecular modeling coming of age [J].
Stone, John E. ;
Hardy, David J. ;
Ufimtsev, Ivan S. ;
Schulten, Klaus .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 29 (02) :116-125